Año: 2024
Journal Impact Factor (JIF): 5.60
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 57/326 | Q1 | T1 | D2 |
Año: 2024
Journal Citation Indicator (JCI): 1,090
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 70/326 | Q1 | T1 | D3 | 78,68 |
Año:
2024
CiteScore:
6,700
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 95/415 | Q1 | T1 | D3 |
| Cancer Research | 79/233 | Q2 | T2 | D4 |
SJR año:
2024
Factor de Impacto:
2,409
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 40/235 | Q1 | T1 | D2 |
| Oncology | 49/417 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| AbbVie | - |
| AstraZeneca | - |
| Celgene | - |
| Daiichi Sankyo | - |
| Gilead Sciences | - |
| Greenwich LifeSciences | - |
| Menarini Group | - |
| MolecularHealth | - |
| Novartis | - |
| Pfizer | - |
| Roche | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | University of Cologne (Germany) | |
| 2 | Hauke, J | University of Cologne (Germany) |
| 3 | Gelmon, K | British Columbia Cancer Agency (Canada) |
| 4 | Marmé, F | Ruprecht Karls University Heidelberg (Germany) |
| 5 | Ernst, C | University of Cologne (Germany) |
| 6 | Martin, M | CIBERONC (Spain) |
| 7 | Untch, M | Helios Kliniken (Germany) |
| 8 | Bonnefoi, H | Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm) (France) |
| 9 | Knudsen, E | Roswell Park Comprehensive Cancer Center (USA) |
| 10 | Im, SA | Seoul National University Hospital (South Korea) |
| 11 | DeMichele, A | Pennsylvania Medicine (USA) |
| 12 | Van't Veer, L | University of California San Francisco (USA) |
| 13 | Kim, SB | University of Ulsan College of Medicine (South Korea) |
| 14 | Bear, H | VCU Health System (USA) |
| 15 | McCarthy, N | Breast Cancer Trials Australia (Australia) |
| 16 | Rhiem, K | University of Cologne (Germany) |
| 17 | Turner, N | Royal Marsden NHS Foundation Trust (England) |
| 18 | Witkiewicz, A | Roswell Park Comprehensive Cancer Center (USA) |
| 19 | Rojo, F | Hosp Univ Fdn Jimenez Diaz (Spain) |
| 20 | Filipits, M | Medical University of Vienna (Austria) |
| 21 | Martin, LA | Royal Marsden NHS Foundation Trust (England) |
| 22 | Fasching, PA | University of Erlangen Nuremberg (Germany) |
| 23 | Schem, C | Mammazentrum Hamburg (Germany) |
| 24 | Becker, K | Medical Faculty of the University of Cologne (Germany) |
| 25 | García-Sáenz, JA | Hospital Clinico San Carlos (Spain) |
| 26 | Kelly, CM | Trinity College Dublin (Ireland) |
| 27 | Reimer, T | University of Rostock (Germany) |
| 28 | Toi, M | Kyoto University (Japan) |
| 29 | Rugo, HS | UCSF Helen Diller Family Comprehensive Cancer Center (USA) |
| 30 | Denkert, C | Philipps University Marburg (Germany) |
| 31 | Gnant, M | Medical University of Vienna (Austria) |
| 32 | Makris, A | Mount Vernon Cancer Centre (England) |
| 33 | Liu, Y | Pfizer Italy (Italy) |
| 34 | Valota, O | Pfizer Italy (Italy) |
| 35 | Felder, B | German Breast Group (Germany) |
| 36 | Weber, K | German Breast Group (Germany) |
| 37 | Nekljudova, V | German Breast Group (Germany) |
| 38 | Loibl, S | German Breast Group (Germany) |
